arrow_back Back to App

Biomedical Research Support: New Drugs and Therapies for Citizens

This act establishes the "Biobonds Program" to help fund research into new drugs and medical devices. Through this program, companies and universities conducting important clinical trials, especially those addressing unmet medical needs, can receive loans. The goal is to accelerate access to innovative therapies that can improve citizens' health and quality of life.
Key points
The "Biobonds Program" will provide loans for clinical trials of new drugs and medical devices.
Priority for funding will be given to research on diseases lacking effective therapies, and studies led by women and minorities.
The government guarantees a portion of the bond principal, encouraging investors to support research while protecting taxpayer money.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_3437
Sponsor: Rep. Rush, Bobby L. [D-IL-1]
Process start date: 2021-05-20
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

LOANS for Biomedical Research Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3437.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-05-20.

What are the main provisions?

Key points include:

  • The "Biobonds Program" will provide loans for clinical trials of new drugs and medical devices.
  • Priority for funding will be given to research on diseases lacking effective therapies, and studies led by women and minorities.
  • The government guarantees a portion of the bond principal, encouraging investors to support research while protecting taxpayer money.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Rush, Bobby L. [D-IL-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Public Investments